Frontotemporal Dementia
📧 Sign up to get email alerts when something new happens for Frontotemporal Dementia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-12-16Clinical Trial Update: Evaluation of [18F]MNI-815 as a Potential PET Radioligand for Imaging Tau Protein in the Brain of Patients With Tauopathies [EARLY_Phase 1]
Early Phase 1 study evaluating the PET radioligand [18F]MNI-815 for imaging tau in tauopathies has been completed, involving Alzheimer's dis…
-
CLINICAL_TRIALS research · 2016-08-09Clinical Trial Update: COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE
This is a completed clinical trial update evaluating the comparative effectiveness of treatments for mild cognitive impairment and dementia …
-
CLINICAL_TRIALS trial_result · 2016-05-16Clinical Trial Update: Dose Finding Study of Nimodipine for the Treatment of Progranulin Insufficiency From GRN Gene Mutations [Phase 1]
Phase 1 dose-finding trial of nimodipine for progranulin insufficiency due to GRN mutations has completed.
-
CLINICAL_TRIALS research · 2016-03-23Clinical Trial Update: Study to Assess the Safety, Tolerability, and Pharmacodynamic (PD) Effects of FRM-0334 in Subjects With Prodromal to Moderate Frontotemporal Dementia With Granulin Mutation [Phase 2]
A Phase 2 clinical trial updating the safety, tolerability, and pharmacodynamic effects of FRM-0334 in individuals with frontotemporal demen…
-
CLINICAL_TRIALS withdrawal · 2016-01-14Clinical Trial Update: A Composite MR Neuroimaging Marker for Alzheimer's Disease
The clinical trial evaluating a composite MR neuroimaging marker for Alzheimer's disease and related cognitive impairment has been withdrawn…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-09-17Clinical Trial Update: Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls. [Phase 2]
Phase 2 clinical trial update evaluating imaging characteristics of florbetapir F-18 in Alzheimer's disease, frontotemporal dementia, and no…
-
CLINICAL_TRIALS trial_result · 2014-03-18Clinical Trial Update: Oxytocin and Social Cognition in Frontotemporal Dementia [NA]
A completed clinical trial evaluating oxytocin and social cognition in people with Frontotemporal dementia (including Pick's disease).
-
CLINICAL_TRIALS trial_result · 2014-03-10Clinical Trial Update: Evaluation of a Handheld Event Related Potential (ERP)/Quantitative Electroencephalography (qEEG) System (COGNISION™) as a Useful Cognitive Biomarker for Alzheimer's Disease.
The study evaluates the COGNISION handheld ERP/qEEG system as a potential cognitive biomarker for Alzheimer's disease. The trial by Neuronet…
-
CLINICAL_TRIALS trial_result · 2014-02-05Clinical Trial Update: Memantine (10mg BID) for the Frontal and Temporal Subtypes of Frontotemporal Dementia [Phase 4]
Phase 4 trial evaluating memantine 10 mg twice daily for frontal and temporal subtypes of frontotemporal dementia has completed with posted …
-
CLINICAL_TRIALS trial_result · 2013-11-04Clinical Trial Update: Safety Study of Intranasal Oxytocin in Frontotemporal Dementia [Phase 1]
Phase 1 safety study evaluating intranasal oxytocin in individuals with Frontotemporal dementia has completed.
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Efficacy and Tolerability of Memantine in Frontotemporal Dementia (FTD) Patients [Phase 2]
Phase 2 trial results assess the efficacy and tolerability of memantine in patients with frontotemporal dementia. The study has completed.
-
CLINICAL_TRIALS trial_result · 2012-11-12Clinical Trial Update: A 52 Week Open Label Trial of Memantine for Frontotemporal Lobar Degeneration [Phase 4]
A 52-week open-label Phase 4 trial evaluated memantine for frontotemporal dementia and has completed.
-
CLINICAL_TRIALS trial_result · 2012-07-06Clinical Trial Update: Performance of AclarusDx™, a Blood-Based Transcriptomic Test for AD, in US Patients Newly Referred to a Memory Center
This clinical trial update reports the performance of AclarusDx, a blood-based transcriptomic test for Alzheimer's disease, in US patients n…
-
CLINICAL_TRIALS trial_result · 2012-06-04Clinical Trial Update: Open Label Pilot Study of the Effects of Memantine on FDG-PET in Frontotemporal Dementia [Phase 3]
An open-label Phase 3 pilot study evaluating memantine's effects on FDG-PET imaging in Frontotemporal dementia has completed.
-
CLINICAL_TRIALS research · 2011-10-28Clinical Trial Update: Study of Social Behavior and Emotion in Frontotemporal Dementia, Alzheimer's Disease and Controls
A UCLA-led clinical trial update describing a study of social behavior and emotion in individuals with frontotemporal dementia, Alzheimer's …
-
CLINICAL_TRIALS research · 2011-07-27Clinical Trial Update: Innovative Biomarkers in Alzheimer's Disease and Frontotemporal Dementia (FTD): Preventative and Personalized
This clinical trial update discusses innovative biomarkers for Alzheimer's disease and frontotemporal dementia to support preventative and p…
-
CLINICAL_TRIALS trial_result · 2011-06-08Clinical Trial Update: A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia [Phase 2]
This Phase 2 pilot trial evaluated the safety and tolerability of galantamine hydrobromide in Frontotemporal dementia and Pick's disease. Th…
-
CLINICAL_TRIALS trial_result · 2009-08-17Clinical Trial Update: Far Infrared Irradiation for the Management, Control and Treatment of Frontotemporal Dementia [Phase 1]
Phase 1 clinical trial evaluating far infrared irradiation for the management, control, and treatment of frontotemporal dementia (Pick disea…
-
CLINICAL_TRIALS trial_result · 2008-09-08Clinical Trial Update: Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
A clinical trial investigating Frontotemporal Dementia and Amyotrophic Lateral Sclerosis has been terminated. The sponsor listed is Assistan…
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Sertraline for the Treatment of Patients With Frontal Lobe Dementia (FLD) [Phase 1]
This Phase 1 trial update from NINDS investigates sertraline as a treatment for Frontal Lobe Dementia.
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Direct Current Brain Polarization in Frontotemporal Dementia [Phase 1]
Phase 1 trial of direct current brain polarization in frontotemporal dementia (Pick's disease) has completed.